News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
Gilead Sciences, Inc. Says U.S. Upholds One Viread Patent
May 21, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LOS ANGELES, May 20 (Reuters) - Gilead Sciences Inc said on Tuesday that U.S. patent officials have upheld one of the four challenged patents covering its AIDS medicine Viread.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Gilead Sciences, Inc.
MORE ON THIS TOPIC
Legal
Judge Rules Against Semaglutide Compounders After Shortage Declared Over
April 25, 2025
·
2 min read
·
Tristan Manalac
Earnings
Tariff Uncertainty Reigns Over Q1 Earnings, With Merck Taking $200M Blow So Far
April 24, 2025
·
3 min read
·
Annalee Armstrong
Drug pricing
Trump Wants To Bring Back International Drug Pricing Policy:
Reuters
April 23, 2025
·
2 min read
·
Annalee Armstrong
Policy
RFK Considers Pulling COVID-19 From CDC’s Vaccine Guidelines for Children:
Politico
April 23, 2025
·
2 min read
·
Tristan Manalac